SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000906709-22-000019
Filing Date
2022-11-04
Accepted
2022-11-04 15:11:28
Documents
61
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q nktr-20220930.htm   iXBRL 10-Q 1423408
2 EX-31.1 nktr2022-09x30xexx311.htm EX-31.1 9533
3 EX-31.2 nktr2022-09x30xexx312.htm EX-31.2 9659
4 EX-32.1 nktr2022-09x30xexx321.htm EX-32.1 5853
  Complete submission text file 0000906709-22-000019.txt   5799894

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT nktr-20220930.xsd EX-101.SCH 43624
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT nktr-20220930_cal.xml EX-101.CAL 65493
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT nktr-20220930_def.xml EX-101.DEF 183967
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT nktr-20220930_lab.xml EX-101.LAB 472039
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT nktr-20220930_pre.xml EX-101.PRE 303028
55 EXTRACTED XBRL INSTANCE DOCUMENT nktr-20220930_htm.xml XML 924934
Mailing Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158
Business Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158 4154825300
NEKTAR THERAPEUTICS (Filer) CIK: 0000906709 (see all company filings)

IRS No.: 943134940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-24006 | Film No.: 221362034
SIC: 2834 Pharmaceutical Preparations